Kyung K. Kang

Yongin, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Gender differences and dose proportionality in the toxicokinetics of udenafil and its active metabolite following oral administration in rodents.

Gender differences and dose proportionality in the toxicokinetics of udenafil and its active metabolite following oral administration in rodents.

Journal: Toxicology and applied pharmacology
Published: July 30, 2020

DA-6034-induced mucin secretion via Ca2+-dependent pathways through P2Y receptor stimulation.

DA-6034-induced mucin secretion via Ca2+-dependent pathways through P2Y receptor stimulation.

Journal: Investigative ophthalmology & visual science
Published: September 13, 2014

Proof of mechanism study of a novel serotonin transporter blocker, DA-8031, using [11C]DASB positron emission tomography and in vivo microdialysis.

Proof of mechanism study of a novel serotonin transporter blocker, DA-8031, using [11C]DASB positron emission tomography and in vivo microdialysis.

Journal: Urology
Published: December 17, 2013

DA-6034 Induces [Ca(2+)]i Increase in Epithelial Cells.

DA-6034 Induces [Ca(2+)]i Increase in Epithelial Cells.

Journal: The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology
Published: July 16, 2013

Effect of DA-8031, a novel oral compound for premature ejaculation, on male rat sexual behavior.

Effect of DA-8031, a novel oral compound for premature ejaculation, on male rat sexual behavior.

Journal: International journal of urology : official journal of the Japanese Urological Association
Published: February 22, 2013

Ejaculatory responses are inhibited by a new chemical entity, DA-8031, in preclinical rodent models of ejaculation.

Ejaculatory responses are inhibited by a new chemical entity, DA-8031, in preclinical rodent models of ejaculation.

Journal: Urology
Published: August 30, 2012

5,7-Dihydroxy-3,4,6-trimethoxyflavone inhibits intercellular adhesion molecule 1 and vascular cell adhesion molecule 1 via the Akt and nuclear factor-κB-dependent pathway, leading to suppression of adhesion of monocytes and eosinophils to bronchial epithelial cells.

5,7-Dihydroxy-3,4,6-trimethoxyflavone inhibits intercellular adhesion molecule 1 and vascular cell adhesion molecule 1 via the Akt and nuclear factor-κB-dependent pathway, leading to suppression of adhesion of monocytes and eosinophils to bronchial epithelial cells.

Journal: Immunology
Published: August 07, 2012

The effect of DA-8159, a novel PDE5 inhibitor, on erectile function in the rat model of hypercholesterolemic erectile dysfunction.

The effect of DA-8159, a novel PDE5 inhibitor, on erectile function in the rat model of hypercholesterolemic erectile dysfunction.

Journal: International journal of impotence research
Published: May 28, 2005

DA-8159, a potent cGMP phosphodiesterase inhibitor, attenuates monocrotaline-induced pulmonary hypertension in rats.

DA-8159, a potent cGMP phosphodiesterase inhibitor, attenuates monocrotaline-induced pulmonary hypertension in rats.

Journal: Archives of pharmacal research
Published: September 12, 2003

DA-8159, a new PDE5 Iihibitor, induces penile erection in conscious and acute spinal cord injured rabbits.

DA-8159, a new PDE5 Iihibitor, induces penile erection in conscious and acute spinal cord injured rabbits.

Journal: European urology
Published: May 28, 2003

Safety evaluation of GX-12, a new HIV therapeutic vaccine: investigation of integration into the host genome and expression in the reproductive organs.

Safety evaluation of GX-12, a new HIV therapeutic vaccine: investigation of integration into the host genome and expression in the reproductive organs.

Journal: Intervirology
Published: February 17, 2003
Showing 1-11 of 11

Last Updated: 09/26/2026